CAR-T细胞培养扩增导致异常DNA甲基化并与不良临床结局相关
本研究探讨CAR-T细胞培养扩增相关的表观遗传改变,发现培养过程中DNA甲基化持续增加,尤其影响T细胞功能相关基因,如TCF7、RUNX1和TOX,且高甲基化伴随转录下调。基于14个培养相关CpG位点的表观遗传特征可预测培养时间,且在培养时间相似的CAR-T产品中,这些位点甲基化水平较高与输注后长期生存显著降低相关。
要点
- CAR-T细胞培养扩增过程中DNA甲基化持续增加,尤其影响T细胞功能相关基因。
- 332个CpG位点甲基化随培养时间近乎线性增加,基于14个位点的特征可预测培养时间。
- 培养时间相似的CAR-T产品中,这些CpG位点高甲基化与输注后长期生存显著降低相关。
核心结论
- CAR-T细胞培养扩增导致基因组特定位点DNA高甲基化,该特征可能反映CAR-T细胞产品潜能丧失。
- 缩短培养时间有益于避免似乎与较差治疗结局相关的功能失调甲基化程序。
研究设计与样本
- 研究类型为体外研究,探讨CAR-T细胞培养扩增相关的表观遗传改变。
主要发现
- 培养过程中DNA甲基化持续增加,尤其位于T细胞功能相关基因内。
- TCF7、RUNX1和TOX等多个基因的高甲基化反映为转录下调。
- 332个CG二核苷酸(CpG)位点甲基化随细胞培养时间近乎线性增加,但相邻CpG位点在同一DNA链上未受一致调控。
- 基于14个培养相关CpG位点的表观遗传特征可在多种培养条件下预测细胞培养时间。
- 在培养时间相似的CAR-T细胞产品中,这些CpG位点DNA甲基化水平较高与输注后长期生存显著降低相关。
关键数值与推荐
- 332个CpG位点甲基化随培养时间近乎线性增加。
- 基于14个培养相关CpG位点的表观遗传特征可预测细胞培养时间。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Chimeric antigen receptor (CAR) T cells provide new perspectives for treatment of hematological malignancies. Manufacturing of these cellular products includes culture expansion procedures, which may affect cellular integrity and therapeutic outcome. In this study, we investigated culture-associated epigenetic changes in CAR T cells and found continuous gain of DNAm, particularly within genes that are relevant for T cell function. Hypermethylation in many genes, such as TCF7, RUNX1, and TOX, was reflected by transcriptional downregulation. 332 CG dinucleotides (CpGs) showed an almost linear gain in methylation with cell culture time, albeit neighboring CpGs were not coherently regulated on the same DNA strands. An epigenetic signature based on 14 of these culture-associated CpGs predicted cell culture time across various culture conditions. Notably, even in CAR T cell products of similar culture time higher DNAm levels at these CpGs were associated with significantly reduced long-term survival post transfusion. Our data demonstrate that cell culture expansion of CAR T cells evokes DNA hypermethylation at specific sites in the genome and the signature may also reflect loss of potential in CAR T cell products. Hence, reduced cultivation periods are beneficial to avoid dysfunctional methylation programs that seem to be associated with worse therapeutic outcome.
引用
- Salz L, Seitz A, Schäfer D, et al. Culture expansion of CAR T cells results in aberrant DNA methylation that is associated with adverse clinical outcome. Leukemia. 2023. PMID: 37452103. doi:10.1038/s41375-023-01966-1
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。